Point72 Hong Kong’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,325
Closed -$178K 2068
2021
Q3
$178K Buy
+2,325
New +$187K 0.01% 1203
2021
Q1
Sell
-3,122
Closed -$204K 1961
2020
Q4
$204K Buy
3,122
+1,477
+90% +$84.9K 0.01% 933
2020
Q3
$81K Buy
+1,645
New +$84.8K 0.01% 596
2020
Q1
Sell
-4,071
Closed -$240K 1093
2019
Q4
$240K Buy
4,071
+3,247
+394% +$176K 0.06% 288
2019
Q3
$42K Sell
824
-887
-52% -$42.2K 0.01% 607
2019
Q2
$72K Buy
+1,711
New +$74.3K 0.02% 561
2019
Q1
Sell
-171
Closed -$7K 1119
2018
Q4
$7K Buy
+171
New +$8.53K ﹤0.01% 591
2017
Q2
Sell
-1,839
Closed -$54K 894
2017
Q1
$54K Buy
+1,839
New +$50.2K 0.07% 217

Other funds holding GMED

Point72 Hong Kong's GMED Position: Q4 2021 in Review

Point72 Hong Kong sold out of Globus Medical (GMED) in Q4 2021, closing a stake of 2,325 shares — an estimated $178K sold.

Point72 Hong Kong first reported a position in GMED in Q1 2017 and held it in 8 quarters. The position peaked at $240K in Q4 2019. 373 funds tracked by Wall St. Rank hold GMED as of Q4 2021.

  • Point72 Hong Kong reported no remaining Globus Medical position as of Q4 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 2,325 Globus Medical shares in Q4 2021, an estimated $178K.
  • Point72 Hong Kong first reported a position in Globus Medical in Q1 2017 and held it in 8 quarters.
  • Point72 Hong Kong's Globus Medical position peaked at $240K in Q4 2019.
  • 373 funds tracked by Wall St. Rank held Globus Medical as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.